Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response
- 1 September 2010
- journal article
- review article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 17 (3) , R213-R231
Abstract
Nuclear receptors comprise a large family of highly conserved transcription factors that regulate many key processes in normal and neoplastic tissues. Most nuclear receptors share a common, highly conserved domain structure that includes a carboxy-terminal ligand-binding domain. However, a subgroup of this gene family is known as the orphan nuclear receptors because to date there are no known natural ligands that regulate their activity. Many of the 25 nuclear receptors classified as orphan play critical roles in embryonic development, metabolism, and the regulation of circadian rhythm. Here, we review the emerging role(s) of orphan nuclear receptors in breast cancer, with a particular focus on two of the estrogen-related receptors (ERRα and ERRγ) and several others implicated in clinical outcome and response or resistance to cytotoxic or endocrine therapies, including the chicken ovalbumin upstream promoter transcription factors, nerve growth factor-induced B, DAX-1, liver receptor homolog-1, and retinoic acid-related orphan receptor α. We also propose that a clearer understanding of the function of orphan nuclear receptors in mammary gland development and normal mammary tissues could significantly improve our ability to diagnose, treat, and prevent breast cancer.Keywords
This publication has 179 references indexed in Scilit:
- Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancersBritish Journal of Cancer, 2006
- Human Transcription Factors Contain a High Fraction of Intrinsically Disordered Regions Essential for Transcriptional RegulationJournal of Molecular Biology, 2006
- RORA, a large common fragile site gene, is involved in cellular stress responseOncogene, 2006
- Flexible netsThe FEBS Journal, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Common origins of MDA-MB-435 cells from various sources with those shown to have melonoma propertiesClinical & Experimental Metastasis, 2004
- XBP-1 increases ERα transcriptional activity through regulation of large-scale chromatin unfoldingBiochemical and Biophysical Research Communications, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- The Orphan Receptor COUP-TFII Regulates G2/M Progression of Breast Cancer Cells by Modulating the Expression/Activity of p21WAF1/CIP1, Cyclin D1, and cdk2Biochemical and Biophysical Research Communications, 2000